Applied BioCode Corporation
NT$28.40-NT$0.70 (-2.41%)
Applied BioCode Corporation’s quoted price sits in the upper half of its reported 52-week range, 10.97% below the high.
TAI · 6861.TW · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
InnoCare Optoelectronics Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.43% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
InnoCare Optoelectronics Corporation’s forward annual dividend is NT$2.00 per share, paid annual. The forward yield is 0.94% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
InnoCare Optoelectronics Corporation’s next earnings report is currently expected on Nov 18, 2026, with estimated earnings per share of NT$0.95. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow InnoCare Optoelectronics Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
InnoCare Optoelectronics Corporation specializes in the invention, production, and worldwide distribution of X-ray flat panel detectors and sensors. These vital components find applications across diverse sectors, including human and animal healthcare, security screening, and industrial inspection, serving clients both in Taiwan and internationally. The company's offerings include crucial elements like thin film transistors and scintillators, alongside a variety of other medical devices. Additionally, they provide essential accessories such as power and Ethernet cables, charging kits, and batteries. Established in 2019, InnoCare Optoelectronics Corporation's primary operations are based in Tainan City, Taiwan, functioning as an affiliate of Innolux Corporation.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:53 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| NT$509.92M-10.23% vs estimate |
| Q1 2024 | Apr 11, 2024 | NT$0.51-66.23% vs estimate | NT$458.32M-16.97% vs estimate |
|---|
| Q4 2023 | Feb 20, 2024 | NT$0.16-91.62% vs estimate | NT$504.98M-11.1% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$28.40-NT$0.70 (-2.41%)
Applied BioCode Corporation’s quoted price sits in the upper half of its reported 52-week range, 10.97% below the high.
NT$73.00-NT$1.10 (-1.48%)
A Plus Biotechnology Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 20.65% below the high.
NT$23.35-NT$0.55 (-2.3%)
Wellell Inc.’s quoted price sits in the lower half of its reported 52-week range, 9.85% below the high.
NT$43.30-NT$0.30 (-0.69%)
HeXun Biosciences Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.53% below the high.
NT$54.70+NT$0.40 (+0.74%)
Dynamic Medical Technologies Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.79% below the high.
NT$50.00-NT$0.50 (-0.99%)
MedFirst Healthcare Services, Inc.’s quoted price sits in the lower half of its reported 52-week range, 20.26% below the high.
NT$16.80-NT$0.25 (-1.47%)
OK Biotech Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 8.75% below the high.
NT$44.20+NT$1.35 (+3.15%)
BenQ Medical Technology Corporation’s quoted price sits in the upper half of its reported 52-week range, 11.42% below the high.